The Global STI Detection Gap: Closing The Loop With Innovation

The Global STI Detection Gap: Closing the Loop with Innovation

Did you know 1 in 25 people worldwide live with an STI, yet 50% never show symptoms?  

Early detection is critical—but traditional methods often miss low-load infections, especially in high-risk populations.

The Data Speaks：

False negatives: A major barrier in underserved regions.

Logistical hurdles: Cold chain requirements limit access.

Turnaround time: Slow results = delayed treatment.

How CowinGene Bridges the Gap

Our STI RCR KIT tackles these challenges head-on:

95% sensitivity: Detects low-load infections missed by others.

Multiple samples：Female vaginal swab/Female cervical swab/Male urethral swab/Urine.

Form selectable:liquid&lyophilized

Why It Matters for Labs

Reduce recurrent infections: Accurate testing = better patient outcomes.

Cost-effective: Fewer repeat tests, lower operational costs.

Scalable: Works in rural clinics or high-throughput hubs.

Join the Discussion

What’s your biggest challenge in STI detection?

DM us for a free workflow analysis or technical specs.